Your Dose of Cannabis Education

Your Dose of Cannabis Education

Only have a minute but want to Learn something every day^™? Sign up to receive Your Dose of Cannabis Education, bringing featured content from our course library right to your inbox each day.

Your Dose of Cannabis Education is based on data from the studies and reviews published in the current peer-reviewed medical journals. Whether you are a healthcare provider, patient, caregiver, an individual working in the healthcare sector, or just a curious person, you can benefit from Your Dose of Cannabis Education.

Wake up every morning and get your dose of unbiased evidence-based cannabis education!

Join Newsletter

Share:

2026-04-10

What are the criteria for early remission of cannabis use disorder?

Early remission applies when an individual who was previously diagnosed with cannabis use disorder has not met any of the diagnostic criteria (except for craving) for a period of at least 3 months but less than 12 months.

American Psychiatric Association. (2022). Diagnostic and statistical manual of mental disorders (5th ed., text rev.; DSM-5-TR). American Psychiatric Publishing. ISBN: 978-0-89042-575-6.

2026-04-09

When is prophylactic therapy for cannabinoid hyperemesis syndrome warranted?

Prophylactic therapy to reduce the frequency, severity and/or recurrence of hyperemetic episodes is recommended for patients with moderate or severe CHS disease. Moderate or severe disease is considered to be 4 or more episodes of nausea and vomiting/year that are so severe such that the patient seeks medical attention in an emergency room or requires hospitalization.

Jiménez Castillo, R. A., et al. (2025). Cannabinoid hyperemesis syndrome: A review. Revista de Gastroenterología de México. https://www.sciencedirect.com/science/article/pii/S2255534X25000581

2026-04-08

Describe the recovery phase of cannabinoid hyperemesis syndrome.

The recovery phase of CHS occurs when the patient stops using cannabis. The nausea and vomiting subside, normal eating habits resume, and the patient gradually returns to baseline health.

Smith, S. A., Safwat, M. A., Piper, B. J., & Addison, M. A. (2025). Unraveling the enigma of cannabinoid hyperemesis syndrome: A narrative review of diagnosis and management. Cureus, 17(8), e90961. https://doi.org/10.7759/cureus.90961

2026-04-07

Describe the hyperemetic phase of cannabinoid hyperemesis syndrome.

The hyperemetic phase involves intractable nausea and vomiting, with severe abdominal pain. Patients typically avoid eating because eating often triggers vomiting and abdominal pain. As the symptoms worsen, many patients develop significant anxiety. Cannabis use continues or even increases during this phase of incapacitating nausea and vomiting. Many patients find that hot showers/ baths provide temporary relief from the nausea and vomiting.

Peles, S., Khalife, R., & Magliocco, A. (2025). Cannabinoid hyperemesis syndrome: A rising complication. Cureus, 17(2), e78958. https://doi.org/10.7759/cureus.78958 and Smith, S. A., Safwat, M. A., Piper, B. J., & Addison, M. A. (2025). Unraveling the enigma of cannabinoid hyperemesis syndrome: A narrative review of diagnosis and management. Cureus, 17(8), e90961. https://doi.org/10.7759/cureus.90961

2026-04-06

In cannabinoid hyperemesis syndrome (CHS), the episodes of vomiting recur in a consistent and recognizable pattern that resembles cyclic vomiting disorders in their timing (onset, duration and frequency) and overall character. Describe the prodromal phase of cannabinoid hyperemesis syndrome.

The prodromal phase of CHS is characterized by morning nausea and intermittent abdominal discomfort. Despite the nausea, the patient is able to eat. This phase can persist anywhere from four months to five years. During this phase, patients often find that cannabis reduces the nausea, which reinforces ongoing use and contributes to the progression into the hyperemetic phase.

Peles, S., Khalife, R., & Magliocco, A. (2025). Cannabinoid hyperemesis syndrome: A rising complication. Cureus, 17(2), e78958. https://doi.org/10.7759/cureus.78958

Learn something every day^™ in your feed…

Follow @The_Answer_Page

Our courses

CBD in Clinical Care V2

A Nationally Approved CME/CE Medical Marijuana Course V2

Cannabis Essentials CME/CE Bundle

New to TheAnswerPage? There’s lots we’d like to share with you and we don’t want you to miss a thing! Be sure to register today for “Your Dose of Cannabis Education” emails where you’ll gain valuable insights in small doses that fit your schedule and also be provided direct access to the archived daily content.

Your Dose of Cannabis Education